Regeneron aims to bolster its capabilities in genomics-driven drug discovery by integrating 23andMe's trove of more than 15 million customer DNA profiles.
Read more: https://unusualwhales.com/news/regeneron-agrees-to-buy-bankrupt-23andme-for-256-million-promises-ethical-use-of-customers-dna-data
Read more: https://unusualwhales.com/news/regeneron-agrees-to-buy-bankrupt-23andme-for-256-million-promises-ethical-use-of-customers-dna-data
Comments